NovoCure Limited

$17.44 -1.19%
NASDAQ: NVCR
Market Cap.: 1.9 B M
P/E: -12.82 x3.3
EPS: -1.36 x 5.9
Earnings Call
3 months, 1 week from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield
Payout
Volume Level
μ 1,062,201
1,171,854 Moderate Low
Performance Ranks (Intraday)
Jersey:

2nd

out of

2

Healthcare:

610th

out of

792

Medical Instruments & Supplies:

64th

out of

91

Peer Group:

8th

out of

11

About

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, …